Genentech

October 8, 2009

SurModics' Drug Delivery to Release Lucentis for Macular Degeneration

Surmodics announces agreement with Genentech/Roche to combine proprietary drug delivery system with Lucentis (ranibizumab) for the treatment of wet macular degeneration.
December 16, 2009

Lucentis: Another Shot in the Eye, Effective TX for ARMD

Lucentis is the second anti-VEGF drug FDA approved for the treatment of wet macular degeneration. It is an effective treatment for wet macular degeneration. The formulation differs from Macugen and Avastin as do the visual results.
April 2, 2010

Avastin Versus Lucentis; And the Winner Is…

Both Avastin and Lucentis are made by the same company. Avastin is not FDA approved for the eye treatment, but why is it used by most doctors?
July 5, 2011

FDA Upholds Denial of Avastin

Though the FDA upheld its decision no longer approve Avastin for the treatment of breast cancer. The drug is still available for eye patients.